Related Experiment Video
Updated: Oct 11, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Safety and Effectiveness of Coronary Angiography or Intervention through the Distal Radial Access: A Meta-Analysis
Jun Cao1, Huaxiu Cai2, Weibin Liu1
1Department of Cardiology, Ganzhou Municipal Hospital, Ganzhou 341000, China.
Insights
Distal radial access (DRA) for coronary angiography is as effective as traditional transradial access (TRA) regarding success rates and hematoma. DRA significantly reduces radial artery occlusion and spasm, enhancing patient safety.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Access
Background:
- Transradial access (TRA) is a common approach for coronary angiography and intervention.
- Distal radial access (DRA) is an alternative technique with potential benefits.
- Evaluating the comparative safety and efficacy of DRA versus TRA is crucial for clinical practice.
Purpose of the Study:
- To conduct a meta-analysis comparing distal radial access (DRA) with transradial access (TRA) for coronary angiography (CAG) or intervention.
- To assess the effectiveness and safety of DRA based on key clinical endpoints.
Main Methods:
- Systematic literature search of randomized controlled trials (RCTs) comparing DRA and TRA.
- Inclusion of studies published between January 1, 2017, and May 4, 2021, from PubMed, Embase, and Cochrane databases.
- Meta-analysis using a random-effects model to evaluate access success, radial artery occlusion, radial artery spasm, and puncture site hematoma rates.
Main Results:
- Six RCTs involving 2825 participants met the inclusion criteria.
- DRA demonstrated a similar access success rate (p=0.1) and lower incidence of puncture site hematoma (p=0.646) compared to TRA.
- DRA showed significantly lower rates of radial artery occlusion (p < 0.001) and radial artery spasm (p=0.029) than TRA.
Conclusions:
- Distal radial access (DRA) offers comparable success rates and hematoma incidence to transradial access (TRA).
- DRA significantly reduces the occurrence of radial artery occlusion and spasm.
- These findings support DRA as a safe and effective alternative access route for coronary angiography and intervention.
Objectives:
Searching the literature for coronary angiography (CAG) or intervention through distal radial access (DRA) and performing a meta-analysis.
Background:
Coronary angiography (CAG) or intervention through distal radial access (DRA) may have a similar success rate, low radial artery occlusion rate, low radial artery spasm rate, and low rate of puncture site hematoma for patients with coronary heart disease. Therefore, the randomized controlled trials (RCTs) were searched, and the data were pooled for meta-analysis to evaluate the effectiveness and safety of DRA.
Methods:
RCTs comparing the CAG or intervention through DRA vs. transradial access (TRA) published between January 1, 2017, and May 4, 2021, were searched in the PubMed, Embase, and Cochrane databases. The endpoints included the rate of access success and the number of radial artery occlusions, radial artery spasms, and puncture site hematomas. The data were extracted, and a random-effects model was used for analysis.
Results:
Among 204 studies, 6 RCTs (with 2825 participants) met the inclusion criteria. Compared to TRA, the access success rate in DRA (p=0.1) and the lower rate of puncture site hematoma were not significantly different (p=0.646), while the radial artery occlusion rate (p < 0.001) and radial artery spasm rate (p=0.029) were significantly lower.
Conclusion:
In summary, DRA has a similar access success rate and incidence of hematoma at the puncture site, but a lower incidence of RAO and spasm compared to TRA. These findings demonstrated that DRA is a safe and effective access for CAG or intervention.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome III: Diagnostic Studies
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...